Fidelity Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.88M Buy
655,893
+72,279
+12% +$648K ﹤0.01% 2108
2025
Q1
$4.38M Sell
583,614
-193,654
-25% -$1.45M ﹤0.01% 2188
2024
Q4
$5.85M Sell
777,268
-1,211,121
-61% -$9.11M ﹤0.01% 2103
2024
Q3
$15.1M Buy
1,988,389
+46,110
+2% +$350K ﹤0.01% 1802
2024
Q2
$12M Buy
1,942,279
+107,203
+6% +$663K ﹤0.01% 1815
2024
Q1
$9.32M Sell
1,835,076
-880,818
-32% -$4.47M ﹤0.01% 1885
2023
Q4
$16.3M Sell
2,715,894
-237,479
-8% -$1.42M ﹤0.01% 1695
2023
Q3
$20.9M Buy
2,953,373
+3,575
+0.1% +$25.3K ﹤0.01% 1570
2023
Q2
$20.8M Sell
2,949,798
-217,712
-7% -$1.53M ﹤0.01% 1620
2023
Q1
$26.4M Sell
3,167,510
-3,953,485
-56% -$33M ﹤0.01% 1503
2022
Q4
$81.7M Buy
7,120,995
+1,413,928
+25% +$16.2M 0.01% 1048
2022
Q3
$71.9M Buy
5,707,067
+519,290
+10% +$6.54M 0.01% 1085
2022
Q2
$54.9M Sell
5,187,777
-3,226,681
-38% -$34.1M 0.01% 1220
2022
Q1
$137M Buy
8,414,458
+4,518,210
+116% +$73.5M 0.01% 940
2021
Q4
$54M Buy
3,896,248
+2,772,069
+247% +$38.4M ﹤0.01% 1396
2021
Q3
$16.2M Sell
1,124,179
-154
-0% -$2.21K ﹤0.01% 1939
2021
Q2
$17.8M Buy
1,124,333
+317,947
+39% +$5.03M ﹤0.01% 1889
2021
Q1
$8.2M Buy
806,386
+102
+0% +$1.04K ﹤0.01% 2104
2020
Q4
$6.01M Sell
806,284
-591,800
-42% -$4.41M ﹤0.01% 2131
2020
Q3
$4.8M Sell
1,398,084
-1,158,500
-45% -$3.98M ﹤0.01% 2085
2020
Q2
$12.2M Hold
2,556,584
﹤0.01% 1741
2020
Q1
$5.11M Buy
2,556,584
+1,270,043
+99% +$2.54M ﹤0.01% 1931
2019
Q4
$4.44M Sell
1,286,541
-502,000
-28% -$1.73M ﹤0.01% 2078
2019
Q3
$5.12M Sell
1,788,541
-1,106,200
-38% -$3.17M ﹤0.01% 2055
2019
Q2
$11M Sell
2,894,741
-573,257
-17% -$2.17M ﹤0.01% 1847
2019
Q1
$28.2M Buy
3,467,998
+475,989
+16% +$3.87M ﹤0.01% 1443
2018
Q4
$24.1M Sell
2,992,009
-761,794
-20% -$6.15M ﹤0.01% 1487
2018
Q3
$28.6M Sell
3,753,803
-664,828
-15% -$5.07M ﹤0.01% 1531
2018
Q2
$25.3M Hold
4,418,631
﹤0.01% 1616
2018
Q1
$21.1M Buy
4,418,631
+1,293,955
+41% +$6.17M ﹤0.01% 1701
2017
Q4
$15.3M Hold
3,124,676
﹤0.01% 1816
2017
Q3
$16.4M Hold
3,124,676
﹤0.01% 1765
2017
Q2
$17.4M Buy
3,124,676
+1,667,791
+114% +$9.27M ﹤0.01% 1737
2017
Q1
$12.2M Buy
1,456,885
+719,162
+97% +$6.04M ﹤0.01% 1890
2016
Q4
$4.67M Buy
737,723
+498,161
+208% +$3.15M ﹤0.01% 2193
2016
Q3
$1.06M Buy
239,562
+58,462
+32% +$258K ﹤0.01% 2453
2016
Q2
$514K Sell
181,100
-818,900
-82% -$2.32M ﹤0.01% 2542
2016
Q1
$2.83M Sell
1,000,000
-6,488,027
-87% -$18.4M ﹤0.01% 2300
2015
Q4
$77.3M Sell
7,488,027
-262,100
-3% -$2.7M 0.01% 1076
2015
Q3
$88.4M Sell
7,750,127
-1,894,804
-20% -$21.6M 0.01% 1005
2015
Q2
$144M Sell
9,644,931
-1,203,089
-11% -$18M 0.02% 860
2015
Q1
$98M Buy
10,848,020
+423,595
+4% +$3.83M 0.01% 1039
2014
Q4
$127M Sell
10,424,425
-221,900
-2% -$2.7M 0.02% 892
2014
Q3
$104M Sell
10,646,325
-89,900
-0.8% -$879K 0.01% 951
2014
Q2
$137M Buy
10,736,225
+1,743,844
+19% +$22.2M 0.02% 828
2014
Q1
$95.1M Buy
8,992,381
+6,388,681
+245% +$67.6M 0.01% 1016
2013
Q4
$19.8M Buy
2,603,700
+2,576,200
+9,368% +$19.6M ﹤0.01% 1716
2013
Q3
$200K Buy
+27,500
New +$200K ﹤0.01% 2574